KLS:0101
TMC Life Sciences Berhad · KLS · Healthcare · MYR · FY for 2026
Figures on this page computed 2026-11-08 10:25 UTC
Last close
n/aMYR
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
42.0xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
- Computed from the filing for 2026
2.0%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
4.4%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
11.9%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.17Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.4%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
Safety is the furthest below its sector's middle: 0.54 against 0.57 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2026
- Sales1.55x
Its own average over 10 years, 254.1M.
- Profit0.69x
Its own average over 10 years, 25.3M.
- Free cash flow-2.63x
Its own average over 10 years, -17.8M.
- Debt1.18x
Its own average over 10 years, 123.1M.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at -2.63 times.
The filed years, as a table
10Each line is 100 at 2017-08-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2017-08-31 | 100.0 | 100.0 | 100.0 |
| 2018-08-31 | 111.4 | 106.8 | 94.8 |
| 2019-08-31 | 128.5 | 80.4 | 92.2 |
| 2020-06-30 | 121.3 | 61.2 | 92.4 |
| 2021-06-30 | 132.5 | 77.8 | 92.4 |
| 2022-06-30 | 160.7 | 159.0 | 92.4 |
| 2023-06-30 | 205.3 | 150.8 | 92.4 |
| 2024-06-30 | 228.3 | 156.1 | 92.4 |
| 2025-06-30 | 227.8 | 13.9 | 92.4 |
| 2026-06-30 | 259.1 | 66.8 | 92.4 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- MYR
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- MYR
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- MYR
Figures behind the shape
Growth
14.3%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate14.3%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
Five-year EPS growth rate-2.9%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
One-year change in net income382.0%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
Returns on capital
2.0%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital2.0%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on equity2.0%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on assets1.6%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
Margins
25.2%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin25.2%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
Operating margin7.0%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
Net margin4.4%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
Free cash flow margin11.9%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
Price
42.0xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings42.0x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
- Computed from the filing for 2026
Price to book0.8x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
- Computed from the filing for 2026
- computed
- Computed from the filing for 2026
EV to EBITDA12.0x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Price to sales ratio1.9x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
Safety
0.17safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equity0.17
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
Current ratio1.69
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
Interest coverage3.7x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
Altman Z-Score2.59
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
What it pays out
0.4%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yield0.4%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
Payout ratio18.7%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Dividend cover ratio14.4x
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- MYR
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.